Hinds, Philip W.

The p53 proto-oncogene can act as a suppressor of transformation

Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell

Cancer-related Molecular PathwaysCell death mechanisms and regulation

Cited by 1,987

The Retinoblastoma Protein Acts as a Transcriptional Coactivator Required for Osteogenic Differentiation

Thomas, D. M., Carty, S. A., Piscopo, D. M., Lee, J.-S., Wang, W.-F., Forrester, W. C., & Hinds, P. W. (2001) · Molecular Cell

Bone Metabolism and DiseasesSarcoma Diagnosis and Treatment

Cited by 361

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis

Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell

Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 329

Requirement for p27KIP1 in Retinoblastoma Protein-Mediated Senescence

Alexander, K., & Hinds, P. W. (2001) · Molecular and Cellular Biology

Telomeres, Telomerase, and SenescenceCancer-related Molecular Pathways

Cited by 164

Role of the Retinoblastoma Protein in Differentiation and Senescence

Thomas, D. M., Yang, H.-S., Alexander, K., & Hinds, P. W. (2003) · Cancer Biology & Therapy

Telomeres, Telomerase, and SenescenceCancer-related Molecular Pathways

Cited by 100

Increased Ezrin Expression and Activation by CDK5 Coincident with Acquisition of the Senescent Phenotype

Yang, H.-S., & Hinds, P. W. (2003) · Molecular Cell

Telomeres, Telomerase, and SenescenceCancer-related Molecular Pathways

Cited by 75

Loss of ARF Sensitizes Transgenic BRAFV600E Mice to UV-Induced Melanoma via Suppression of XPC

Luo, C., Sheng, J., Hu, M. G., Haluska, F. G., Cui, R., Xu, Z., Tsichlis, P. N., Hu, G.-F., & Hinds, P. W. (2013) · Cancer Research

Melanoma and MAPK PathwaysDNA Repair Mechanisms

Cited by 31